Biotech · Private company · Chapel Hill, NC, US
Sollus Therapeutics, Inc.
Track this companyFree. Adds Sollus Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- Enhancing antigen sensitivity of BCMA CAR T cells for durable clinical responses inmultiple myelomaFiscal year 2026 · $373.5KNIH RePORTER 1R41CA310458-01A1 · fetched Nov 12, 2026
- Development of a modular customizable screening platform for chimeric antigenreceptor optimizationFiscal year 2026 · $322.6KNIH RePORTER 1R41TR006357-01 · fetched Nov 12, 2026